Identification and Application of Ketogenic Properties of Intestinal Stem Cell

The present invention provides compositions comprising β-hydroxybutyrate, cyclic or linear β-hydroxybutyrate oligomers, and/or β-hydroxybutyrate ester derivatives, or pharmaceutically-acceptable salts thereof. In various embodiments, the compositions are encapsulated by nanoparticles, such as nanoparticles comprising, e.g., poly(lactic-co-glycolic acid). In additional embodiments, the invention provides methods of using such compositions to induce intestinal stem cell regeneration and/or treat radiation-induced intestinal damage in a subject.

Researchers

George Eng / Omer Yilmaz / Chia-Wei Cheng / Fang Wang

Departments: David H Koch Institute for Integrative Cancer Res, Department of Biology
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Therapeutics: Regenerative Medicine, Small Molecules
Impact Areas: Healthy Living

  • beta-hydroxybutyrate encapsulated plga nano particle compositions
    United States of America | Granted | 11,266,617

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies